Amikacin Sulfate Salt CAS 149022-22-0 Raw Materials Amikasin Sulfate Purity 99%

Product Description

Payment & Shipping Terms Supply Capacity
Unit Price:1.0 USDProduction Capacity:1000kg/month
Trade Term:FOB,CFR,CIFPacking:25kg/Drum
Payment Terms:Bitcoin, T/T, WU, Money GramDelivery Date:4days
Min. Order:10 Gram
Means of Transport:Ocean, Air, Land

1. Basic Info


Product Name:Amikacin Sulfate Salt
Synonyms:AMIKACIN SULFATE 1:1.8;Amikacin sulfate salt;(2S)-4-AMino-N-{(1R,2S,3S,4R,5S)-5-aMino-2-[(3-aMino-3-deoxy-a-D-glucopyranosyl)oxy]-4-[(6-aMino-6-deoxy-a-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanaMide sulfate (1:2);AMIKASIN SULFATE
CAS:149022-22-0
MF:C22H43N5O13.2H2O4S
MW:781.759
EINECS:254-648-6


Amikacin sulfate salt (cas 149022-22-0) MSDS


1.

1.1

IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

Product identifiers

Product name Amikacin sulfate salt

Product Number A2324

Brand Jia Ye

CAS-No. 149022-22-0

1.2

Relevant identified uses of the substance or mixture and uses advised against

Identified uses: Laboratory chemicals, Manufacture of substances

2.

2.1

2.2

2.3

3.

3.1

4.

4.1

HAZARDS IDENTIFICATION

Classification of the substance or mixture

Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.

This substance is not classified as dangerous according to Directive 67/548/EEC.

Label elements

The product does not need to be labelled in accordance with EC directives or respective national laws.

Other hazards - none

COMPOSITION/INFORMATION ON INGREDIENTS

Substances

FIRST AID MEASURES

Description of first aid measures

General advice

Consult a physician. Show this safety data sheet to the doctor in attendance.

If inhaled

If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.

In case of skin contact

Wash off with soap and plenty of water. Consult a physician.

In case of eye contact

Flush eyes with water as a precaution.

- A2324

If swallowed

Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.

Most important symptoms and effects, both acute and delayed

Aminoglycosides are associated with significant nephrotoxicity and/or ototoxicity.

Indication of any immediate medical attention and special treatment needed

no data available

FIREFIGHTING MEASURES

Extinguishing media

Suitable extinguishing media

Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

Special hazards arising from the substance or mixture

Carbon oxides, nitrogen oxides (NOx), Sulphur oxides

Advice for firefighters

Wear self contained breathing apparatus for fire fighting if necessary.

Further information

no data available

ACCIDENTAL RELEASE MEASURES

Personal precautions, protective equipment and emergency procedures

Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Avoid

breathing dust.

Environmental precautions

Do not let product enter drains.

Methods and materials for containment and cleaning up

Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed

containers for disposal.

Reference to other sections

For disposal see section 13.

HANDLING AND STORAGE

Precautions for safe handling

Avoid formation of dust and aerosols.

Provide appropriate exhaust ventilation at places where dust is formed.

Conditions for safe storage, including any incompatibilities

Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Recommended storage temperature: 2 - 8 °C

Specific end uses

no data available

EXPOSURE CONTROLS/PERSONAL PROTECTION

Control parameters

Components with workplace control parameters

Exposure controls

Appropriate engineering controls

Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and

at the end of workday.

- A2324

Personal protective equipment

Eye/face protection

Use equipment for eye protection tested and approved under appropriate government standards

such as NIOSH (US) or EN 166(EU).

Skin protection

Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique

(without touching glove's outer surface) to avoid skin contact with this product. Dispose of

contaminated gloves after use in accordance with applicable laws and good laboratory practices.

Wash and dry hands.

The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and

the standard EN 374 derived from it.

Body Protection

Choose body protection in relation to its type, to the concentration and amount of dangerous

substances, and to the specific work-place., The type of protective equipment must be selected

according to the concentration and amount of the dangerous substance at the specific workplace.

Respiratory protection

Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,

use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and

approved under appropriate government standards such as NIOSH (US) or CEN (EU).


Other safety information

no data available

STABILITY AND REACTIVITY

Reactivity

no data available

Chemical stability

no data available

Possibility of hazardous reactions

no data available

Conditions to avoid

no data available

Incompatible materials

Strong oxidizing agents

Hazardous decomposition products

Other decomposition products - no data available

TOXICOLOGICAL INFORMATION

Information on toxicological effects

Acute toxicity

LD50 Oral - rat - > 4.000 mg/kg

Skin corrosion/irritation

no data available

Serious eye damage/eye irritation

no data available

Respiratory or skin sensitization

no data available

Germ cell mutagenicity

no data available

Carcinogenicity

IARC:

No component of this product present at levels greater than or equal to 0.1% is identified as

probable, possible or confirmed human carcinogen by IARC.

Reproductive toxicity

Laboratory experiments have shown teratogenic effects.

Reproductive toxicity - rat - Subcutaneous

Effects on Fertility: Litter size (e.g.; # fetuses per litter; measured before birth).

Reproductive toxicity - mouse - Subcutaneous

Effects on Newborn: Growth statistics (e.g., reduced weight gain).

Developmental Toxicity - rat - Subcutaneous

Effects on Embryo or Fetus: Fetotoxicity (except death, e.g., stunted fetus). Specific Developmental

Abnormalities: Musculoskeletal system. Specific Developmental Abnormalities: Homeostasis

Developmental Toxicity - mouse - Subcutaneous

Effects on Embryo or Fetus: Fetotoxicity (except death, e.g., stunted fetus). Specific Developmental

Abnormalities: Musculoskeletal system.

Specific target organ toxicity - single exposure

no data available

Specific target organ toxicity - repeated exposure

no data available

- A2324

Aspiration hazard

no data available

Potential health effects

Inhalation

Ingestion

Skin

Eyes

May be harmful if inhaled. May cause respiratory tract irritation.

May be harmful if swallowed.

May be harmful if absorbed through skin. May cause skin irritation.

May cause eye irritation.

Signs and Symptoms of Exposure

Aminoglycosides are associated with significant nephrotoxicity and/or ototoxicity.

Additional Information

RTECS: WK1961200


Category: Pharmaceuticals


Contact Us
Welcome to our website !